Impact of kynurenine metabolites on B and T cells in multiple sclerosis and allergies

Chronic inflammation is central to both multiple sclerosis (MS) and allergic conditions, though their pathological outcomes differ. In MS, inflammation leads to demyelination and neurodegeneration in the central nervous system, while in allergies, it causes localized tissue swelling and irritation....

Full description

Bibliographic Details
Published in:	IBRO Neuroscience Reports
Main Authors:	Ivana Stanković Matić, Lara Saftić Martinović, Ines Benčik, Ana Novaković, Nada Starčević Čizmarević
Format:	Article
Language:	English
Published:	Elsevier 2025-12-01
Subjects:	Allergic conditions B immune cells Chronic inflammation Kynurenic pathways Multiple sclerosis Tryptophan metabolism
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667242125001666

Similar Items

The kynurenine pathway in Alzheimer’s disease: a meta-analysis of central and peripheral levels
by: Brisa S. Fernandes, et al.
Published: (2023-05-01)

Kynurenine Pathway Metabolites as Potential Biomarkers in Chronic Pain
by: Andrew Auyeung, et al.
Published: (2023-05-01)

Characterization of Redox Environment and Tryptophan Catabolism through Kynurenine Pathway in Military Divers’ and Swimmers’ Serum Samples
by: Laura Sánchez Chapul, et al.
Published: (2022-06-01)

Exercise-induced adaptations in the kynurenine pathway: implications for health and disease management
by: Marcus Vinicius dos Santos Rangel, et al.
Published: (2025-03-01)

Abnormal Activation of Tryptophan-Kynurenine Pathway in Women With Polycystic Ovary Syndrome
by: Siyu Wang, et al.
Published: (2022-06-01)

Investigation of Genetic Variants Associated with Tryptophan Metabolite Levels via Serotonin and Kynurenine Pathways in Patients with Bipolar Disorder
by: Claudia Pisanu, et al.
Published: (2022-11-01)

The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a systematic review and meta-analysis of cerebrospinal fluid studies
by: Mehmet Enes Inam, et al.
Published: (2023-08-01)

Current evidence for a role of the Kynurenine pathway of tryptophan metabolism in Multiple Sclerosis
by: Michael D. Lovelace, et al.
Published: (2016-08-01)

Differential Levels of Tryptophan–Kynurenine Pathway Metabolites in the Hippocampus, Anterior Temporal Lobe, and Neocortex in an Animal Model of Temporal Lobe Epilepsy
by: Soumil Dey, et al.
Published: (2022-11-01)

The Kynurenine Pathway in Obese Middle-Aged Women with Normoglycemia and Type 2 Diabetes
by: Justyna Kubacka, et al.
Published: (2022-05-01)

Direct effects of remote ischemic preconditioning on post-exercise-induced changes in kynurenine metabolism
by: Paulina Brzezińska, et al.
Published: (2024-11-01)

Seasonal Plasticity in Tryptophan Metabolism Provides New Insights Into Physiological Adaptation in Snake Hibernation
by: Yuting Wei, et al.
Published: (2025-09-01)

Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives
by: Tamás Biernacki, et al.
Published: (2020-06-01)

Maternal Tryptophan Catabolites and Insulin Resistance Parameters in Preeclampsia
by: Zainab Abdulameer Jasim, et al.
Published: (2023-09-01)

Assessing Urinary Metabolomics in Giant Pandas Using Chromatography/Mass Spectrometry: Pregnancy-Related Changes in the Metabolome
by: Maosheng Cao, et al.
Published: (2020-04-01)

Tryptophan recovery index as a new biomarker for fitness
by: Alexander Pichler, et al.
Published: (2022-06-01)

Kynurenine pathway metabolites are associated with gray matter volume in subjects with schizophrenia
by: Sumiao Zhou, et al.
Published: (2022-08-01)

The Role of Kynurenine and Its Metabolites in Comorbid Chronic Pain and Depression
by: Onella Athnaiel, et al.
Published: (2022-10-01)

The Tryptophan-Kynurenine Metabolic System Is Suppressed in Cuprizone-Induced Model of Demyelination Simulating Progressive Multiple Sclerosis
by: Helga Polyák, et al.
Published: (2023-03-01)

Brain Kynurenine Pathway Metabolite Levels May Reflect Extent of Neuroinflammation in ALS, FTD and Early Onset AD
by: Annelies Heylen, et al.
Published: (2023-04-01)

Electrochemical detection of kynurenic acid in the presence of tryptophan with the carbon paste electrode modified with the flower-like nanostructures of zinc oxide doped with terbium
by: Ali Amir Poursaeed, et al.
Published: (2023-09-01)

The role of kynurenine and kynurenine metabolites in psoriasis
by: Akyurek Fikret, et al.
Published: (2024-12-01)

Comparison of serum kynurenine pathway metabolites between patients with first-episode and recurrent major depressive disorder
by: Lao Guohui, et al.
Published: (2023-08-01)

Microbiota-Derived Tryptophan Metabolite Indole-3-Propionic Acid-Emerging Role in Neuroprotection
by: Maja Owe-Larsson, et al.
Published: (2025-09-01)

Immune Influencers in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic Pathway
by: Masaru Tanaka, et al.
Published: (2021-06-01)

Research progress on the kynurenine pathway in the prevention and treatment of Parkinson’s disease
by: Ping Chen, et al.
Published: (2023-12-01)

Phase 1 study to access safety, tolerability, pharmacokinetics, and pharmacodynamics of kynurenine in healthy volunteers
by: Mohammad Al‐Mahdi Al‐Karagholi, et al.
Published: (2021-04-01)

Quinoline Quest: Kynurenic Acid Strategies for Next-Generation Therapeutics via Rational Drug Design
by: Masaru Tanaka, et al.
Published: (2025-04-01)

Exploring the Tryptophan Metabolic Pathways in Migraine-Related Mechanisms
by: Tamás Körtési, et al.
Published: (2022-11-01)

Memory Enhancement with Kynurenic Acid and Its Mechanisms in Neurotransmission
by: Diána Martos, et al.
Published: (2022-04-01)

The microbial production of kynurenic acid using Yarrowia lipolytica yeast growing on crude glycerol and soybean molasses
by: Magdalena Rakicka-Pustułka, et al.
Published: (2022-08-01)

The Effect of Systemic Nitroglycerin Administration on the Kynurenine Pathway in the Rat
by: Gábor Nagy-Grócz, et al.
Published: (2017-06-01)

Are Kynurenines Accomplices or Principal Villains in Dementia? Maintenance of Kynurenine Metabolism
by: Masaru Tanaka, et al.
Published: (2020-01-01)

Some CSF Kynurenine Pathway Intermediates Associated with Disease Evolution in Amyotrophic Lateral Sclerosis
by: Hugo Alarcan, et al.
Published: (2021-05-01)

Memantine and the Kynurenine Pathway in the Brain: Selective Targeting of Kynurenic Acid in the Rat Cerebral Cortex
by: Renata Kloc, et al.
Published: (2024-08-01)

Kynurenine diminishes the ischemia-induced histological and electrophysiological deficits in the rat hippocampus
by: Katalin Sas, et al.
Published: (2008-11-01)

Immune and Neuroendocrine Trait and State Markers in Psychotic Illness: Decreased Kynurenines Marking Psychotic Exacerbations
by: Livia De Picker, et al.
Published: (2020-01-01)

Uncovering the Link Between Kynurenic Acid Pathway and Kidney Failure
by: Carolla El Chamieh, et al.
Published: (2025-05-01)

Metabolic Syndrome and Schizophrenia: Adding a Piece to the Interplay Between the Kynurenine Pathway and Inflammation
by: Jacopo Sapienza, et al.
Published: (2025-03-01)

Increased burden of rare variants in GWAS associated genes in familial multiple sclerosis
by: Aleksander Turk, et al.
Published: (2025-07-01)